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Abstract—Cardiovascular Disease (CVD) is an important 
cause of disability and death among individuals with Diabetes 
Mellitus (DM). International clinical guidelines for the 
management of Type 2 DM (T2DM) are founded on primary and 
secondary prevention and favor the evaluation of CVD related 
risk factors towards appropriate treatment initiation. CVD risk 
prediction models can provide valuable tools for optimizing the 
frequency of medical visits and performing timely preventive and 
therapeutic interventions against CVD events. The integration of 
explainability modalities in these models can enhance human 
understanding on the reasoning process, maximize transparency 
and embellish trust towards the models’ adoption in clinical 
practice. The aim of the present study is to develop and evaluate 
an explainable personalized risk prediction model for the fatal or 
non-fatal CVD incidence in T2DM individuals. An explainable 
approach based on the eXtreme Gradient Boosting (XGBoost) and 
the Tree SHAP (SHapley Additive exPlanations) method is 
deployed for the calculation of the 5-year CVD risk and the 
generation of individual explanations on the model’s decisions. 
Data from the 5- year follow up of 560 patients with T2DM are 
used for development and evaluation purposes. The obtained 
results (AUC=71.13%) indicate the potential of the proposed 
approach to handle the unbalanced nature of the used dataset, 
while providing clinically meaningful insights about the ensemble 
model’s decision process. 
Keywords—Cardiovascular Disease, Diabetes, machine 
learning, explainability, interpretability, unbalanced data 
I. INTRODUCTION 
Cardiovascular Disease (CVD) is a class of disorders of the 
heart and blood vessels, that severely affects people with 
Diabetes Mellitus (DM), being a major cause of disability and 
death and a barrier to sustainable development. Individuals with 
Type 2 DM (T2DM), the most common form of DM, are at a 
substantially increased risk of CVD compared to individuals 
without DM, experiencing CVD events at an earlier age and 
presenting higher CVD-related mortality rates [1].  
A focus on CVD prevention in high-risk populations can 
reduce mortality and decrease the imposed economic burden 
from Coronary Heart Disease (CHD) and stroke. International 
clinical guidelines for DM management endorse the adoption 
of cost-effective preventive strategies, which rely on the regular 
assessment of CVD risk factors for the early detection of high-
risk individuals, and trigger targeted interventions in terms of 
healthy lifestyle behavioural changes and pharmacological 
treatment prescription [2]. Within this context, computational 
CVD risk prediction models have great potential to facilitate 
primary care physicians in accurate CVD risk stratification, 
enable timely and efficient therapeutic strategies, and eliminate 
redundant screening procedures for patients at a low CVD risk, 
thus optimizing patient care pathways and improving quality of 
life and productivity.  
Among a variety of data-driven approaches, survival 
analysis and regression models have gained the most 
widespread acceptance in the field of CVD risk prediction 
models. Such methodologies have been deployed towards the 
development of the most thoroughly studied CVD risk 
calculators, including Framingham [3], SCORE [4], and 
DECODE [5]. Nevertheless, these models underestimate the 
CVD risk in T2DM individuals due to the underrepresentation 
of DM patients in the corresponding cohorts [6]. The UKPDS 
risk engine, dedicated to T2DM patients, has exhibited varying 
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performance, mainly related to the selection criteria of the data 
underpinning the model, that have resulted in poor reflection of 
a broader range of T2DM patients [7].  
Along these lines, improvements in the performance of 
computational models predicting health outcomes have been 
pursued through the application of more sophisticated 
approaches, investigating techniques in the areas of statistics 
and machine learning (ML), such as Logistic Regression, 
Artificial Neural Networks (ANN), Support Vector Machines 
(SVM), Decision Trees (DT), and Random Forests (RF) [8] 
[9][10]. More recently, the eXtreme Gradient Boosting 
(XGBoost) algorithm has attracted significant attention due to 
its computational speed, generalization capabilities and high 
predictive performance, and has been employed in various 
clinical contexts towards CVD risk prediction, chronic kidney 
disease diagnosis, T2DM onset prediction, and mortality 
prediction in patients with acute coronary syndrome [11] 
[12][13]. In the case of DM, the use of ANN, SVM, Bayesian 
Networks, Self Organizing Maps (SOM), and RF, combined 
with a limited number of traditional risk factors, has also been 
investigated for the diagnosis of DM and its long-term 
complications, including CVD, retinopathy, kidney disease and 
neuropathy [14] [15] [16] [17].   
Despite the promising performance reported in such studies, 
the models’ intricate structure has so far impeded the generation 
of clinically useful explanations on the reasoning process 
behind the delivered decisions, thus hampering the adoption of 
more accurate yet complex risk prediction models in clinical 
practice. Today, the advent of explainable artificial intelligence 
opens up new opportunities, offering model-specific and 
model-agnostic explainability techniques that outweigh any 
concerns regarding the “black-box” nature of risk calculators, 
promote transparency and enhance users’ trust [18]. In terms of 
model-agnostic techniques, Local Interpretable Model-agnostic 
Explanations (LIME) and SHapley Additive exPlanation 
(SHAP) have been widely used in different domains in order to 
provide insights about features’ contribution in the models’ 
decision process. However, limited explainabe risk prediction 
models have been proposed for assisting disease prognosis and 
diagnosis [19] [20]. 
In the present study, an explainable approach, based on the 
combined use of the XGBoost algorithm and a modification of 
the SHAP method, i.e. Tree SHAP, is deployed towards the 
development of an explainable personalized risk prediction 
model for the fatal or non-fatal CVD incidence in T2DM. A set 
of well-established CVD-related risk factors are considered for 
the calculation of a T2DM individual’s 5-year risk score to 
experience a CVD incidence for the first time. XGBoost’s 
computational speed and efficient data handling capabilities are 
utilized towards exploring nonlinear complex interactions 
between risk factors. A sophisticated ensemble learning scheme 
is applied with the aim of addressing the unbalanced nature of 
the used dataset. A thorough analysis, based on the consistent 
and computationally efficient Tree SHAP framework, is 
performed in order to reveal meaningful insights about the 
ensemble model’s decision process and the contribution of the 
considered risk factors in the final CVD risk scores. To the best 
of the authors’ knowledge, this is the first work proposing an 
explainable XGBoost-based ensemble approach for the 
calculation of the CVD risk in T2DM. 
II. DATASET 
Data collected from a 5-year follow up of 560 T2DM 
patients at the Hippokration General Hospital of Athens, 
including 41 patients (7.32%) with CVD incidents during their 
follow-up period, were used for development and evaluation 
purposes [15]. Out of the 41 patients, four patients experienced 
stroke and the rest experienced CHD. Baseline demographic, 
lifestyle, laboratory and treatment data, that adequately reflect 
the health status of T2DM patients, were considered in order to 
compose the model’s input space. 
III. METHODOLOGY 
Fig. 1 depicts the conceptual framework of the proposed 
explainable XGBoost-based ensemble approach. It comprises 
the decision space, featuring the calculation of the 5-year CVD 
 
Fig. 1. Conceptual framework. A combination scheme based on weighted averaging was applied in order to merge the individual models’ outputs and generate 
explanations on the ensemble model’s decisions.  
 
risk scores, and the explanation space where explanations on 
the model’s decisions are generated.  
A. Ensemble learning scheme 
1) Sub-sampling approach: Considering that training and 
testing data are usually derived from the same distribution for 
the development of most prediction models, the unbalanced 
nature (low number of CVD incidents) of the used dataset 
would result in over-fitting to the majority (negative instances) 
class. In order to avoid over-fitting, an ensemble learning 
method, based on a sub-sampling approach, was applied 
towards the generation of appropriate training subsets from the 
original data. Multiple individual models were trained on these 
subsets and combined to produce the final CVD risk scores 
[15]. In particular, the initial training dataset was divided into 
positive (for CVD) and negative (for CVD) instances. Different 
sub-samples were subsequently created, in which a 1:2 ratio 
between the minority (positive instances) and the majority 
(negative instances) class was preserved, by using all positive 
instances from the initial training dataset and double sized 
randomly selected negative instances. In this way, six different 
training subsets (n=6) were derived and used for training six 
XGBoost-based individual models.  
2) Ensemble model: The outputs of the trained individual 
models were combined by means of weighted averaging, as 𝑦 𝑥 = $% 𝑤'×	𝑦'(𝑥)%',$   (1) 
where 𝑦 𝑥  is the final risk score in the log-odds scale, n 
denotes the number of the trained individual models (n=6), wm 
= [0.15, 0.4, 0.05, 0.1, 0.05, 0.25] and ym (x) represent the 
weights and the outputs of the trained models in the log-odds 
scale, respectively. A brute-force search approach was adopted 
in order to generate an optimal weights’ combination for the six 
individual models. The final CVD risk scores were obtained by 
transforming the calculated log-odds scores into the 
corresponding probabilities, as 
𝑝(𝑥) = 𝑒𝑦 𝑥(1+𝑒𝑦 𝑥 ) .  (2) 
B. eXtreme Gradient Boosting (XGBoost) algorithm 
eXtreme Gradient Boosting (XGBoost) constitutes an 
efficient and scalable variant of the Gradient Boosting Machine 
(GBM) algorithm, leveraging the power of decision tree 
ensembles towards performance optimization and goodness-of-
fit improvement [21]. In XGBoost, multiple decision trees, 
which are also called weak learners, operate in parallel, and 
solve both classification and regression problems. GBM 
utilizes the gradient descent to create a new tree, based on the 
residual errors of previously generated trees, aiming at the 
minimization of the objective function 
         Obj = L + Ω. (3) 
In (3), L is the training loss function, which measures the 
model’s performance on the training data 
 L = (𝑦1 − 	𝑦3)456,$ , (4) 
where 𝑦1  and 	𝑦3  are the model’s target value and output, 
respectively, and N is the number of instances in the training 
data. Ω is a regularization term, which penalizes the complexity 
of the model in order to avoid over-fitting, and is defined as 
 Ω = γΤ+$4 𝜆 𝑤8498,$ , (5) 
where T is the number of leaves, wj is the weight vector, 
representing score on the j-th leaf, λ is L2 regularization and γ 
is a penalization parameter on the number of leaves. The 
objective function at the t-th iteration can be simplified by using 
the Taylor expansion and fixed term simplifications, and 
eventually it can be defined as: 𝑂𝑏𝑗(>) = [𝑔𝑖𝑓𝑡(𝑥𝑖) + 12	ℎ𝑖𝑓𝑡2(𝑥𝑖)]𝑁𝑖=1 + 𝛺(𝑓𝑡), (6) 
where  𝑔1 = ∂y(t−1) 	𝑙𝑜𝑠𝑠	(𝑦, 𝑦(𝑡−1)), (7) ℎ1 = 𝜕𝑦(𝑡−1)2 𝑙𝑜𝑠𝑠	(𝑦, 𝑦(𝑡−1)), (8) 
and ft represents the tree structure that is added to minimize the 
objective function.  
The identification of the optimal tree structure at each step is 
performed through a greedy method that enables the selection 
of the best split candidate for the addition of new leaves, based 
on the split-induced gain. The gain can be defined as: 𝑔𝑎𝑖𝑛	 = 	 12 ( 𝑔1)41∈STℎ1 + 𝜆1∈ST + ( 𝑔1)41∈SUℎ1 + 𝜆1∈SU − ( 𝑔1)41∈Sℎ1 + 𝜆1∈S − 𝛾, (9) 
where I is the set of instances that are assigned to the leaf before 
the split, and 𝐼X, 𝐼Y	are the instance sets of left and right leaf 
nodes after the split, respectively. This iterative process 
continues until the tree acquires its defined maximum depth.  
1) Hyperparameters tuning: In the present study, a brute-
force grid-search approach with parallelized performance 
evaluation was applied towards the optimal tuning of 
TABLE I 
XGBOOST HYPERPARAMETERS 
 
Hyperparameter Value 
Learning rate 0.5 
Number of estimators 1000 
Minimum split loss [0.5, 1.0, 0.5, 0.5, 1.0, 2.5] 
Maximum tree depth 3 
Minimum sum of instance 
weights in a child 1 
Sub-sample ratio of training 
instances 0.8 
Sub-sample ratio of columns 
for each tree 0.5 
Sub-sample ratio of columns 
for each level 0.5 
L2 regularization term 2 
L1 regularization term 0 
Weight balance between 
positive-negative class 4 
 
XGBoost’s hyperparameters. Table I summarizes the 
combination of hyperparameters’ values that achieved error 
minimization in the validation set. This combination was used 
for tuning the six XGBoost-based individual models. The value 
of the minimum split loss was differentiated among the 
individual models towards the generation of tree structures with 
different levels of complexity. The number of estimators, 
representing the maximum number of trees that were created 
during the training phase, was set to 1000. An early stopping 
criterion was also applied in order to avoid over-fitting, by 
setting the number of early stopping rounds, i.e. the number of 
trees, after which tree generation stops unless validation scores 
continue to improve, to 50. 
2) Feature selection: Despite the relatively low number of 
risk factors composing the input space, the importance of the 
initially considered risk factors was investigated, and an 
incremental feature selection technique was followed, in order 
to ensure the selection of the most discriminant and informative 
features, contributing in beneficial data splits across the 
models’ structure. To this end, feature weight, which is defined 
as the number of times a feature is used for data splitting, was 
used as a measure of importance. Average importance values 
were firstly estimated for each of the 16 features across the six 
individual models, based on the calculated outputs in the 
validation set. A hierarchical classification of the features was 
subsequently performed according to their average importance 
values, as depicted in Fig. 2, and individual models were trained 
by using the top-k-ranked features iteratively for k ∈ (1, 2, …, 
16). Τhis process was repeated for the different 
hyperparameters’ combinations, generated by grid-search. The 
top-13-ranked features, which achieved the highest AUC score 
in the validation set, were finally selected to compose the 
individual models’ input space.  
C. Tree SHAP  
Shapley Additive exPlanations (SHAP) constitutes a 
unified framework, founded on an additive feature attribution 
method, for generating unique explanation models able to 
provide explanations on individual models’ decisions in the 
form of particular feature contributions [22]. It is inspired by 
the concept of shapley values, which in Game Theory describe 
the players’ contribution to the result of a coalitional game, and 
has gained broad acceptance due to its ability to satisfy local 
accuracy, missingness and consistency. According to SHAP, a 
unique explanation model has the form: 𝜑1 = |𝑆|! (𝑀 − |𝑆| − 1)!𝑀! [𝑓𝑆∪{𝑖}(𝑥𝑆∪{𝑖}) − 𝑓𝑠(𝑥𝑆)]𝑆⊆𝑀]{𝑖} , (10) 
where 𝜑1 is the Shapley value of the i-th feature, Μ is the set of 
all features, S is a subset of |S| features, 𝑓c∪{1} and 𝑓c represent 
trained models with the i-th feature present and withheld, 
respectively, and xS represents the values of features included in 
the S subset. SHAP approximates the output value 𝑓d(𝑆) as a 
conditional expectation function of the trained model,  𝑓d(𝑆) = 𝐸[𝑓(𝑥)|𝑥c]	, (11) 
where E[f(x)] is the trained model’s base value. 
In the present study, Tree SHAP, which is a variant of 
SHAP for tree-based models, characterized by reduced 
computational complexity, was deployed towards the 
generation of explanations on the ensemble model’s output 
[23]. To this end, the individual SHAP values of the considered 
risk factors were calculated for each of the individual models’ 
outputs. Taking into account the inherent linearity of shapley 
values, a weighted averaging approach, similar to the one 
 
Fig. 2. Average feature importance values across the individual models based 
on feature weight. 
 
    
Fig. 3. Left panel: Summary plot depicting the influence of the considered risk factors and their range of effects across the ensemble model’s decisions. Risk 
factors are ranked based on their impact on the model’s decisions. Positive and negative SHAP values contribute to the calculation of higher and lower CVD 
risk scores, respectively. Right panel: Decision plot illustrating the followed prediction paths towards the calculation of CVD risk scores (presented in the log-
odds scale) within the model’s decision process. 
applied for obtaining the ensemble model’s outputs, was 
adopted in order to estimate the SHAP values, reflecting the 
contribution of each risk factor in the final risk scores.   
D. Evaluation framework  
The generalization abilities of the developed risk prediction 
model were evaluated by applying stratified 10-fold cross-
validation, which resulted into 10 data subsets of identical size, 
approximately preserving the minority representation of the 
initial dataset. During the training phase of each iteration, 
training and validation sets were partitioned based on a 90/10 
ratio. The ensemble model’s predictive performance was 
assessed in terms of Sensitivity (SENS). The Area Under the 
Curve (AUC) was employed as a measure of the ensemble 
model’s discrimination ability. 
In terms of the obtained SHAP explanations, different visual 
representations were generated by using the SHAP package 
(https://github.com/slundberg/shap) in order to capture risk 
factors’ influence and underlying interactions’ effects on the 
ensemble model’s outputs. Summary plots were produced to 
depict the contribution of the considered risk factors and their 
range of effects across the model’s decisions. Decision plots 
were derived towards identifying potential prediction paths in 
the model’s decision process. Hierarchical clustering analysis 
was also performed in order to reveal risk factor coalitions 
towards specific model’s decisions [24].  
IV. RESULTS AND DISCUSSION  
A. Evaluation of the model’s performance 
Table ΙI summarizes the proposed model’s performance, 
indicating that the ensemble model achieved acceptable 
discrimination performance (AUC value: 71.13±11.69%). 
Acceptable sensitivity levels were also obtained, demonstrating 
the model’s ability to handle the unbalanced nature of the used 
dataset by correctly identifying positive for CVD incidents. 
B. Explanations on the model’s decisions 
The results of the performed SHAP analysis yielded 
meaningful insights regarding the impact of the considered risk 
factors on the ensemble model’s decisions. Evidence was also 
provided on the effectiveness of the proposed approach in 
delivering explainable CVD risk scores, highlighting its 
potential to support clinical decision making. 
A summary plot, depicting the range of influence of the 
considered risk factors across the model’s outputs, is presented 
in the left panel of Fig. 3. Colored points were used to illustrate 
the distribution of the generated decisions’ impact among the 
risk factors. It can be seen that Body Mass Index (BMI), HDL 
cholesterol and Glycosylated Hemoglobin (HbA1c) constituted 
the most influential risk factors, determining to a great extent 
the final CVD risk scores across the data instances. Particularly, 
high levels of BMI and HDL cholesterol and normal HbA1c 
levels were assigned negative SHAP values, thus contributing 
in the calculation of lower CVD risk scores. Lower HbA1c 
levels appeared to contribute in the generation of higher CVD 
risk scores, despite constituting a protective factor against 
CVD, which was probably associated with the health profile 
characteristics of patients in the used dataset. Smoking habit, 
triglycerides, and older age were also shown to contribute in the 
increase of the estimated risk scores, while low pulse pressure 
was attributed negative SHAP values, thus imposing a decrease 
in the calculated probabilities. Finally, positive SHAP values 
were generated for lipid-lowering therapy, indicating that the 
existence of hyperlipidemia disorders led to the calculation of 
higher risk scores. 
TABLE II 
PREDICTIVE PERFORMANCE OF THE PROPOSED RISK PREDICTION MODEL 
 
Mean ± SD (%) 
AUC SENS 
71.13±11.69 71.00±23.85 
 
 
Fig. 4. Clustering of generated decisions based on explanation similarity. Red and blue areas represent risk factors’ effects that promote calculation of higher 
and lower CVD risk scores, respectively. Notable features, that are present in the annotated (through red and blue horizontal lines) clusters, are shown. 
A decision plot, summarizing the prediction paths that were 
followed within the ensemble model’s decision process, is 
presented in the right panel of Fig. 3, where risk factors’ SHAP 
values accumulate towards the final CVD risk scores, depicted 
in the top horizontal axis. It appears that a common prediction 
path was followed for the majority of data instances in the 
beginning of the decision process, featuring risk factors of 
lower influence such as parental history of diabetes, 
hypertension and fasting glucose. However, as more influential 
risk factors were considered, individual prediction paths started 
to differentiate, evolving towards the calculation of the final 
risk scores. 
Clustering of data instances, influenced by the same 
coalitions of risk factors, revealed explanation similarities 
among the generated decisions. The results of hierarchical 
clustering analysis are depicted in Fig. 4. Notable sets of risk 
factors were identified, having contributed in the calculation of 
lower (blue areas) or higher (red areas) CVD risk scores. In 
particular, normal or high levels of HDL cholesterol, BMI and 
HbA1c, low or normal levels of triglycerides and pulse pressure, 
and absence of smoking habit, contributed with negative SHAP 
values, leading to the generation of lower CVD risk scores. On 
the other hand, positive SHAP values were attributed in the case 
of co-existence of low HDL cholesterol levels, high levels of 
total cholesterol and triglycerides, normal or high levels of BMI 
and HbA1, and lipid lowering therapy, thereby promoting the 
generation of higher CVD risk scores. 
V.  CONCLUSION  
Within the framework of the present study, an innovative 
approach, based on the XGBoost algorithm and the SHAP 
method, towards the development of an explainable CVD risk 
prediction model, was proposed. An ensemble learning strategy 
was adopted and a combination scheme based on weighted 
averaging was applied to merge the outputs of the trained 
individual models and the corresponding shapley values of the 
considered risk factors. The combined use of XGBoost and 
ensemble learning achieved acceptable performance despite the 
low number of CVD incidents, demonstrating the method’s 
potential to handle the unbalanced nature of the used dataset. 
The obtained explanations revealed clinically meaningful 
insights about the reasoning process behind the ensemble 
model’s decisions, by capturing the most influential risk factors 
and highlighting the effect of underlying interactions. Future 
work concerns the extension of the proposed explainable 
approach in order to enable the generation of explanations 
within more advanced ensemble learning strategies, with the 
ultimate goal to facilitate health professionals in DM patients’ 
risk stratification. 
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